Search
Fidanacogene elaparvovec
go.drugbank.com/drugs/DB16783ApprovedInvestigationalFactor IX (FIX) deficiency) who are negative for neutralizing antibodies to variant AAV serotype Rh74. … from week 12 to month 15 compared to an ABR of 4.43 for the pre-treatment period.
Vildagliptin
go.drugbank.com/drugs/DB04876ApprovedInvestigational[L32803] Vildagliptin is also available as Eucreas, a fixed-dose formulation with metformin for adults in who do not adequately glycemic control from monotherapy. … It is used to manage type II diabetes mellitus, where GLP-1 secretion and insulinotropic effects are impaired.
Products: MIU TWOPheniramine
go.drugbank.com/drugs/DB01620ApprovedPheniramine is a first-generation antihistamine in the alkylamine class, similar to [brompheniramine] and [chlorpheniramine].
Mixtures: Care One Flu and Sore ThroatMifepristone
go.drugbank.com/drugs/DB00834ApprovedInvestigationalAs a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary cushing syndrome. … The two marketed forms of mifepristone are Mifeprex® (mifepristone 200mg) and Korlym™ (mifepristone 300mg). Currently under investigation for use in psychotic depression (phase 3 trials).
Nitroglycerin
go.drugbank.com/drugs/DB00727ApprovedInvestigational[L42445] It is also used to induce intraoperative hypotension.[L7099] … [A180166,A180172] Its use as a treatment for angina dates back to 1879 and is still used to treat and prevent angina.[A249970] Nitroglycerin causes vasodilation in both arteries and veins.
Products: RECTOGESIC OINTMENT 0.2% w/w, NITROGLICERINA DOC GENERICILofentanil
go.drugbank.com/drugs/DB09174ExperimentalIllicitLofentanil is an analog of fentanyl and is one of the most potent opioids available today. … It displays most similarity to carfentanil (4-carbomethoxyfentanyl) and is considered to be slightly more potent than this drug.
Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin SyndromeTrastuzumab emtansine
go.drugbank.com/drugs/DB05773ApprovedInvestigationalT-DM1 combines two strategies-- anti-HER2 activity and targeted intracellular delivery of the potent anti-microtubule agent, DM1 (a maytansine derivative)--to produce cell cycle arrest and apoptosis. … The FDA label has two precautions. First that trastuzumab emtansine and trastuzumab cannot be interchanged.
Voretigene neparvovec
go.drugbank.com/drugs/DB13932ApprovedInvestigationalVoretigene Neparvovec-rzyl (VN-rzyl) is an adeno-associated virus vector-based gene therapy. An adeno-associated virus is a small virus that infects humans and other primates. It is not pathogenic and it causes a very mild immune respons...
Ublituximab
go.drugbank.com/drugs/DB11850ApprovedInvestigationalwas approved by the US FDA for the treatment of relapsing forms of multiple sclerosis, becoming the first and only anti-CD20 monoclonal antibody for multiple sclerosis allowing for administration in a one-hour … [A244210] Ublituximab is a chimeric anti-CD20 IgG1κ antibody produced in the rat YB2/0 cell line to target a unique epitope and enhance ADCC compared to other approved anti-CD20 antibodies such as [rituximab
Ramipril
go.drugbank.com/drugs/DB00178ApprovedInvestigationalRamipril is a prodrug belonging to the angiotensin-converting enzyme (ACE) inhibitor class of medications. It is metabolized to ramiprilat in the liver and, to a lesser extent, kidneys. … Ramiprilat is a potent, competitive inhibitor of ACE, the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII).
Mixtures: RAMIPRIL E AMLODIPINA DOC GENERICI, RAMIPRIL E AMLODIPINA DOC GENERICIProducts: RAMIPRIL DOC GENERICI, RAMIPRIL MYLAN GENERICS